Exploring Digital Strategies for Clinical Trial Recruitment

Patient recruitment is a significant strategic component of clinical trials, one that has historically been a major bottleneck in the process. A majority of trials fail to meet enrollment targets on time, and many are closed or terminated due to a failure to recruit enough participants.

Among the recruitment challenges faced by study teams are the lack of patient awareness that there are clinical trials available as an option for their condition and overly restrictive eligibility criteria. Digital innovations are helping tackle these and other challenges to transform the process and reduce recruitment time by automating patient matching, pre-screening, and personalized engagement.

Clinical trial recruitment is the critical first phase of a clinical trial in which research teams identify study participants who reflect the population for which the medical product is being developed. It is a critical phase in the research lifecycle because of its potential impact on the duration and quality of the study.

A collaborative ecosystem of stakeholders is involved in the clinical trial recruitment process. Key players and their responsibilities include research sponsors that fund and design the trial, clinical investigators responsible for leading the trial at specific sites, study coordinators who manage daily operations, healthcare providers who identify eligible patients, and the patients or participants themselves.

The process includes three stages:

• Identifying and screening: Study teams identify potential study participants through physician referrals, medical record reviews, or advertisements.
  
• Outreach and informed consent: Outreach materials are provided to engage and educate potential participants, followed by a formal consent document that details the study’s risks, benefits, and procedures.
  
• Enrollment and retention: After participants are formally initiated into the study, study teams follow a continuous process of keeping enrolled participants from dropping out.

Because genetic, environmental, and lifestyle factors can result in different reactions to a new medical treatment, it is important to ensure diversity in study populations. Scientific accuracy is improved with representation across race, ethnicity, age, and gender.

Clinical trial recruitment has shifted to the use of digital, data-driven strategies that combine AI-powered patient identification with targeted outreach to reduce delays and costs. By leveraging electronic health records, claims data, and digital marketing, sponsors are better able to identify eligible patients, streamline screening, and improve enrollment diversity.

Clinical trials are the foundation for medical advances, so it's crucial that they accurately represent the population who might eventually use the treatment. Having lots of volunteers sounds great, but if they're all from similar backgrounds, the results won't apply broadly. Recruitment challenges , such as low numbers or a lack of diversity, can result in delays, increased costs, weak data, and compromised study quality.

It can be hard to convince eligible people to join. Often, they don't even know trials exist. Logistical barriers like transportation and work schedules also get in the way. And for many, there are deeply personal concerns like skepticism and a lack of trust.

The stats are pretty staggering: 85% percent of clinical trials fail to recruit enough participants on time and within budget. Only about 4% of adults in the United States participate, a rate that hasn't budged since the mid-1990s, and it's even lower among underrepresented communities. Past medical abuses of minority groups created lasting mistrust that researchers are still working to overcome. And without enough participants from a wide range of backgrounds, healthcare providers can't be sure that a treatment will work well for everyone who might need it.

Choosing a recruitment partner is a strategic decision that can help ensure timely, high-quality enrollment and adherence to critical standards. But finding the right one can be daunting, and there are several different types to consider, depending on the size of the organization and specific priorities.

Contract research organizations (CROs) can handle everything from study design to data management, and they often offer recruitment services. Specialized recruitment companies focus exclusively on finding and enrolling patients, while digital recruitment platforms use online tools like clinical trial management software and data analytics to reach potential participants. Each offers different opportunities for boosting enrollment numbers, and selecting a partner is an important decision that depends on the type of support needed.

Start by clarifying how much of the recruitment process you want your internal teams to manage. Organizations with limited resources may benefit from working with partners that can provide broad support for recruitment, while more established teams may prefer to seek out support for specific challenges. For trials that require flexibility across geographies or phases, a more adaptable partner model may be the best choice.

With so much potential support available, how do pharmaceutical companies and other organizations decide where to focus? Best practices for recruitment success in the digital age can depend on how familiar a potential participant is with the study. It starts with initial awareness, moving through qualification and engagement, and eventually leading to enrollment.

1. Build community-based partnerships and outreach. Collaborate with trusted local organizations, leaders, and clinics that already serve your target communities. This is key to building trust, especially with underrepresented groups. Make sure you're advertising the trial to a diverse population, and dedicate time to researching your institution's reputation in the community. One study on inclusion and diversity in clinical trials found a clear, actionable step you can take: Build community engagement into budgets, timelines, and scopes of work.
2. Use social listening to understand patient perspectives: Join online support groups, patient-run blogs, and forums to find out how patients are talking to each other about their conditions. What are their biggest concerns? Do they have certain lingo they use to describe their conditions? Use what you learn to help shape the way you advertise the study and how you talk to potential participants.
3. Experiment with digital advertising and hyper-targeting: Use insights gathered from social listening and other methods to create targeted segments and run ads to those segments. However, sponsors and investigators must follow federal guidelines.
4. Leverage online clinical trial portals: Government databases and research networks allow potential participants to learn about clinical research and find studies that they may be able to join.
5. Tap into patient databases and registries: Patients who have opted into databases such as rare disease registries are easier to find and more likely to be interested in participating in a clinical trial because they're actively seeking support. Plus, these patients can advocate for the clinical trial in their own communities, which provides an additional layer of trust.
6. Integrate electronic health records (EHR) data for real-time eligibility checks: Integrating a CRM like Salesforce with EHR systems can help you check inclusion and exclusion criteria to automatically qualify participants during patient recruitment. This helps you avoid wasting time and resources targeting the wrong people, so you can focus energy on patients who match the study criteria.
7. Apply AI for patient matching and insights: By streamlining the process, AI in clinical trials can improve patient matching accuracy and speed. You don't get bogged down by an overwhelming number of potential participants.
8. Use conversational AI for pre-screening: Agentic AI can take it a step further by engaging with candidates to ask follow-up questions and respond to their questions about the study. The effect is twofold: It can help give candidates all the information they need (adding transparency to the process), and it alleviates workload by pre-screening prospects and instantly passing their information along to coordinators.
9. Automate site-level engagement: When it's time to convert qualified candidates to enrollment, automated engagement, such as email sequences, can help ensure sites follow up quickly while potential participants are aware and interested in the study.

Agentforce Life Sciences can help boost recruitment outcomes in several ways. It helps speed up clinical trials by unifying patient and trial data to enable more efficient management of patient journeys and identification of ideal sites and patients. This helps reduce delays, screen failures, and patient dropouts.

Built-in CRM capabilities enable more targeted and personalized outreach at scale. At the same time, agentic AI helps streamline pre-screening and can automate tasks across the recruitment workflow. Integration with provider systems and EHRs further improves efficiency by connecting fragmented data while real-time dashboards and insights enable teams to monitor performance and continuously optimize recruitment strategies.

Here are some key differences between legacy approaches and Agentforce Life Sciences recruitment solutions

New data-driven, AI-powered strategies are helping to solve the bottleneck of patient recruitment for clinical trials by automating the identification of eligible candidates, increasing study diversity, and enhancing patient engagement. As a result, clinical trial recruitment is rapidly shifting to a patient-centric approach that treats participants as partners rather than just data sources.

The integration of digital platforms and AI-driven, tech-enabled solutions makes it possible to speed patient identification and recruitment and facilitate engagement and address participant needs early in the process. These connected platforms accelerate trial timelines, improve retention, and provide real-time data flow between sites and participants.